Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald B Appel

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Progress in Cardiovascular Diseases|December 9, 2004
Angiotensin II receptor antagonists: role in hypertension, cardiovascular disease, and renoprotectionGerald B Appel, Alice S Appel
Blood Purification|February 26, 2018
Treatment of Rapidly Progressive Glomerulonephritis in the ElderlyGerald B Appel, Wai L Lau
Kidney International|January 6, 2020
Antigens, antibodies, and membranous nephropathy: a decade of progressSyeda Behjat Ahmad, Gerald B Appel
Nature Clinical Practice. Nephrology|January 29, 2009
An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseasesAlice S Appel, Gerald B Appel
Journal of the American Society of Nephrology : JASN|November 6, 2010
Updates on the treatment of lupus nephritisAndrew S Bomback, Gerald B Appel
Nature Reviews. Nephrology|June 26, 2013
Glomerular disease: ANCA-associated GN--to PLEX or not to PLEX?Andrew S Bomback, Gerald B Appel
Blood Purification|January 25, 2013
New diagnostic tests and new therapies for glomerular diseasesGerald B Appel, Alice Sue Appel
Nature Reviews. Nephrology|October 3, 2012
Pathogenesis of the C3 glomerulopathies and reclassification of MPGNAndrew S Bomback, Gerald B Appel
Nature Reviews. Nephrology|July 25, 2012
Lupus nephritis: Implications of the new ACR lupus nephritis guidelinesHans-Joachim Anders, Gerald B Appel
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 19, 2013
Diagnostic tests and treatment options in glomerular disease: 2014 updateJonathan Hogan, Prince Mohan, Gerald B Appel
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Progress in Cardiovascular Diseases|December 9, 2004
Angiotensin II receptor antagonists: role in hypertension, cardiovascular disease, and renoprotectionGerald B Appel, Alice S Appel
Blood Purification|February 26, 2018
Treatment of Rapidly Progressive Glomerulonephritis in the ElderlyGerald B Appel, Wai L Lau
Kidney International|January 6, 2020
Antigens, antibodies, and membranous nephropathy: a decade of progressSyeda Behjat Ahmad, Gerald B Appel
Nature Clinical Practice. Nephrology|January 29, 2009
An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseasesAlice S Appel, Gerald B Appel
Journal of the American Society of Nephrology : JASN|November 6, 2010
Updates on the treatment of lupus nephritisAndrew S Bomback, Gerald B Appel
Nature Reviews. Nephrology|June 26, 2013
Glomerular disease: ANCA-associated GN--to PLEX or not to PLEX?Andrew S Bomback, Gerald B Appel
Blood Purification|January 25, 2013
New diagnostic tests and new therapies for glomerular diseasesGerald B Appel, Alice Sue Appel
Nature Reviews. Nephrology|October 3, 2012
Pathogenesis of the C3 glomerulopathies and reclassification of MPGNAndrew S Bomback, Gerald B Appel
Nature Reviews. Nephrology|July 25, 2012
Lupus nephritis: Implications of the new ACR lupus nephritis guidelinesHans-Joachim Anders, Gerald B Appel
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 19, 2013
Diagnostic tests and treatment options in glomerular disease: 2014 updateJonathan Hogan, Prince Mohan, Gerald B Appel
Pageof 14